In the CCLG-ALL-2008 cohort, a significantly higher mean CD123 expression (55.12 ± 2.05%) was found in survivors as compared to the non-survivors (40.53 ± 4.483%; p = 0.0057) (Figures 1A, D). The gene discussed is IL3RA; the disease is acute lymphoblastic leukemia.